Integrated optical phased array (OPA) devices have been widely studied as a solution for solid-state light detection and ranging technology in the autonomous driving application. In this work, a phase-combining unit (PCU) is proposed and studied. With a given number (N) of phase shifters, instead of the general N (phase shifters) to N (emitters) control, the PCU can enable an N to 2N-1 control, which efficiently suppresses the aliasing effect. The theoretical analysis, numerical simulation, and experimental proof-of-concept have been completed in this work. The results show that a maximum suppression of 92.54% can be achieved for the grating lobes in simulation, and an average 53.76% is tested for one grating lobe in the experiment. In conclusion, the PCU can be used as a universal aliasing suppression unit on many types of integrated OPA devices.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1364/OL.450524 | DOI Listing |
Integrated optical phased array (OPA) devices have been widely studied as a solution for solid-state light detection and ranging technology in the autonomous driving application. In this work, a phase-combining unit (PCU) is proposed and studied. With a given number (N) of phase shifters, instead of the general N (phase shifters) to N (emitters) control, the PCU can enable an N to 2N-1 control, which efficiently suppresses the aliasing effect.
View Article and Find Full Text PDFDis Markers
December 2016
CHU Clermont-Ferrand, Intensive Care Unit, Department of Perioperative Medicine, Estaing University Hospital, 63000 Clermont-Ferrand, France; Clermont Université, Université d'Auvergne, EA 7281, R2D2, 63000 Clermont-Ferrand, France.
Acute respiratory distress syndrome (ARDS) is an acute-onset hypoxic condition with radiographic bilateral lung infiltration. It is characterized by an acute exudative phase combining diffuse alveolar damage and lung edema followed by a later fibroproliferative phase. Despite an improved understanding of ARDS pathobiology, our ability to predict the development of ARDS and risk-stratify patients with the disease remains limited.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!